Optibiotix Health (OPTI)

 

Latest News

OptiBiotix Health to present in Barcelona

OptiBiotix Health said it had an abstract accepted for presentation at ProBiota 2018 in Barcelona from February 7 to 9. Pro...

Presentation of data at European Conference

RNS Number: 0536C OptiBiotix Health PLC 17 January 2018 OptiBiotix Health plc ("OptiBiotix" or the "Company") Presentation of research data at European Conference: ProBiota 2018 OptiB i ot i x H ealth p l c (A I M :O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, h i g hchole s te r ol, d ia b ete s and skin care, a nn o un c...

Shareholder Circular and Notice of General Meeting

RNS Number: 2663B OptiBiotix Health PLC 08 January 2018 OptiBiotix Health plc ("OptiBiotix" or the "Company") Shareholder Circular and Notice of General Meeting OptiB i ot i x H ealth p l c (A I M: O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, h i g h chole s te r ol and d ia b ete s announces that, further to the annou...

Directorate Changes

RNS Number: 1283B OptiBiotix Health PLC 08 January 2018 OptiBiotix Health plc ("OptiBiotix" or the "Company") Directorate changes OptiB i ot i x H ealth p l c (A I M: O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, h i g h chole s te r ol, d ia b ete s announces that further to the announcement dated 5 December 2017, Rich...

All News

DateHeadlineSource
17-01-18OptiBiotix Health to present in BarcelonaStockMarketWire
17-01-18Presentation of data at European ConferenceRNS
08-01-18Shareholder Circular and Notice of General MeetingRNS
08-01-18Directorate ChangesRNS
14-12-17Exercise of warrant and issue of equityRNS
12-12-17Manufacturing, supply & profit sharing agreementRNS
05-12-17OptiBiotix Health chairman stands downStockMarketWire
05-12-17Proposed directorate changesRNS
28-11-17OptiBiotix Health mulls capital re-organisationStockMarketWire
28-11-17Capital reorganisationRNS
17-11-17Exercise of Warrant and Issue of EquityRNS
08-11-17SlimBiome? commercial & product development updateRNS
01-11-17Manufacturing, supply & profit sharing agreementRNS
26-10-17OptiBiotix to present researchStockMarketWire
26-10-17Presentation of researchRNS
24-10-17OptiBiotix signs product supply agreementStockMarketWire
24-10-17LPLDL? supply agreement with GalenicumRNS
04-10-17Successful launch of products at Supply Side WestRNS
19-09-17Technical, regulatory & commercial updateRNS
13-09-17OptiBiotix Health signs MoU with Bened BiomedicalStockMarketWire
13-09-17Strategic partnership with Bened BiomedicalRNS
11-09-17Holding(s) in CompanyRNS
07-09-17Invited to present at Expoquimia in BarcelonaRNS
06-09-17Investor eveningRNS
05-09-17Manufacturing Agreement with Tata ChemicalsRNS
01-09-17Exercise of Options and Issue of EquityRNS
30-08-17OptiBiotix loss widens on higher expensesStockMarketWire
30-08-17Half-year ReportRNS
24-08-17OptiBiotix Health to launch LPLDL at Supply Side West in USStockMarketWire
24-08-17US product launch of LPLDL? at trade showRNS
22-08-17OptiBiotix seals new deal with SaccoStockMarketWire
22-08-17Global manufacturing & supply agreement with SaccoRNS
31-07-17Total Voting RightsRNS
26-07-17Market launch for LPLDL? capsules in GermanyRNS
17-07-17OptiBiotix Health seals deal with Pharmabiota NZStockMarketWire
17-07-17Supply agreement with Pharmabiota LtdRNS
11-07-17SweetBiotix? development: Results of taste studyRNS
06-07-17Grant of OptionsRNS
15-06-17All resolutions passed at AGM of OptiBiotixStockMarketWire
15-06-17Result of AGMRNS

RSS feeds

  • Editorial news feed for LSE:OPTI Editorial
  • Regulatory news feed for LSE:OPTI Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account